Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus

Aim The aim of the present study was to assess the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus. Methods A total of 188 patients were enrolled who had type 2 diabetes mellitus with poor glycemic profiles (hemoglobin A1c [HbA1c] ≥6.2%). Patients were assigned t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Geriatrics & gerontology international 2018-04, Vol.18 (4), p.631-639
Hauptverfasser:	Tago, Motoko, Oyama, Jun‐ichi, Sakamoto, Yoshiko, Shiraki, Aya, Uchida, Fumi, Chihara, Atsuko, Ikeda, Hideo, Kuroki, Shigetaka, Gondo, Shigeki, Iwamoto, Taketo, Uchida, Yasufumi, Node, Koichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Age groups Aged Blood Glucose blood pressure Body Mass Index cardiovascular risks Diabetes Diabetes Mellitus, Type 2 - drug therapy dipeptidyl peptidase‐4 inhibitor Glycated Hemoglobin A Humans renal function Sitagliptin Phosphate - adverse effects Sitagliptin Phosphate - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aim The aim of the present study was to assess the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus. Methods A total of 188 patients were enrolled who had type 2 diabetes mellitus with poor glycemic profiles (hemoglobin A1c [HbA1c] ≥6.2%). Patients were assigned to one of three age groups (
ISSN:	1444-1586 1447-0594
DOI:	10.1111/ggi.13235